Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naturetti in Chronic Functional Constipation
NCT00994851Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2009
- Primary completion
- Aug 2012
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic functional constipation (CIC) comparing Naturetti with Placebo (2 arms). Primary endpoints: Evaluation of the evacuation frequency during the treatment and follow-up period at 45 days, Evaluation of the stools consistency during the treatment and follow-up period at 45 days and 1 more. Started Sep 2009; status: completed.
02
Drugs
cassia fistula
03
Conditions
chronic functional constipation (CIC)
Beyond the preview
Go deeper on NCT00994851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00994851.